Emerging evidence indicates that MAPK4 regulation of the AKT signalling pathway may be involved in the pathogenesis of tumours, such as lung adenocarcinoma, colon cancer, and prostate cancer [18]. This evidence concerns the gene MAPK4 and prostate carcinoma.